Sangamo Therapeutics, Inc.
- SGMO
- OTC
- Biotechnology
- Gene Therapy
- Genomic Medicine
$0.07
Quote Jul 1, 2026, 08:00 PM UTC
−55.20%over the last month
Max drawdown −64.2%From 1-month high −62.7%3 months −74.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Sangamo Therapeutics
Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Employees
127
Founded
1995
Market value
$30.7M
Quote Jul 1
Floor
$0.07
3.5% below price
Resistance
$0.08
12.0% above price
Price vs analyst targets
14 analysts
Lowest target
$2.00Highest target
$19.00
$2.00Highest target
$19.00
- Price $0.07
- Average target $7.25
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 9697% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SGMOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free